Does POLATUZUMAB VEDOTIN Cause Decreased appetite? 86 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 86 reports of Decreased appetite have been filed in association with POLATUZUMAB VEDOTIN (POLIVY). This represents 1.8% of all adverse event reports for POLATUZUMAB VEDOTIN.
86
Reports of Decreased appetite with POLATUZUMAB VEDOTIN
1.8%
of all POLATUZUMAB VEDOTIN reports
23
Deaths
58
Hospitalizations
How Dangerous Is Decreased appetite From POLATUZUMAB VEDOTIN?
Of the 86 reports, 23 (26.7%) resulted in death, 58 (67.4%) required hospitalization, and 7 (8.1%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for POLATUZUMAB VEDOTIN.
What Other Side Effects Does POLATUZUMAB VEDOTIN Cause?
Disease progression (1,131)
Off label use (692)
Anaemia (344)
Blood lactate dehydrogenase increased (307)
Drug ineffective (305)
Neutropenia (303)
Death (295)
Covid-19 (286)
Febrile neutropenia (286)
Pyrexia (285)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which POLATUZUMAB VEDOTIN Alternatives Have Lower Decreased appetite Risk?
POLATUZUMAB VEDOTIN vs POLATUZUMAB VEDOTIN-PIIQ
POLATUZUMAB VEDOTIN vs POLIDOCANOL
POLATUZUMAB VEDOTIN vs POLYETHYLENE GLYCOL
POLATUZUMAB VEDOTIN vs POLYETHYLENE GLYCOL 3350
POLATUZUMAB VEDOTIN vs POLYETHYLENE GLYCOL 3350\POTASSIUM\SODIUM BICARBONATE\SODIUM